- Home
- FOLD vs VAL Comparison
FOLD vs VAL Comparison
Compare FOLD & VAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- VAL
- Stock Information
- Founded
- FOLD 2002
- VAL 1975
- Country
- FOLD United States
- VAL Bermuda
- Employees
- FOLD N/A
- VAL N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- VAL Oil & Gas Production
- Sector
- FOLD Health Care
- VAL Energy
- Exchange
- FOLD Nasdaq
- VAL Nasdaq
- Market Cap
- FOLD 2.9B
- VAL 3.0B
- IPO Year
- FOLD 2007
- VAL N/A
- Fundamental
- Price
- FOLD $6.12
- VAL $49.88
- Analyst Decision
- FOLD Buy
- VAL Hold
- Analyst Count
- FOLD 10
- VAL 7
- Target Price
- FOLD $16.22
- VAL $45.33
- AVG Volume (30 Days)
- FOLD 5.5M
- VAL 1.5M
- Earning Date
- FOLD 08-07-2025
- VAL 07-30-2025
- Dividend Yield
- FOLD N/A
- VAL N/A
- EPS Growth
- FOLD N/A
- VAL N/A
- EPS
- FOLD N/A
- VAL 4.29
- Revenue
- FOLD $543,141,000.00
- VAL $2,458,300,000.00
- Revenue This Year
- FOLD $19.87
- VAL N/A
- Revenue Next Year
- FOLD $23.15
- VAL $0.23
- P/E Ratio
- FOLD N/A
- VAL $11.64
- Revenue Growth
- FOLD 28.25
- VAL 30.82
- 52 Week Low
- FOLD $5.51
- VAL $27.15
- 52 Week High
- FOLD $12.65
- VAL $84.20
- Technical
- Relative Strength Index (RSI)
- FOLD 51.42
- VAL 71.88
- Support Level
- FOLD $5.66
- VAL $48.54
- Resistance Level
- FOLD $6.45
- VAL $51.27
- Average True Range (ATR)
- FOLD 0.21
- VAL 1.76
- MACD
- FOLD 0.07
- VAL 0.49
- Stochastic Oscillator
- FOLD 64.89
- VAL 86.43
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About VAL Valaris Limited
Valaris Ltd is an offshore contract drilling company. The company provides offshore contract drilling services to the international oil and gas industry with operations in almost every offshore market across six continents. Its business consists of four operating segments: Floaters, which includes drillships and semisubmersible rigs; Jackups; ARO; and Other, which consists of management services on rigs owned by third parties. It generates the majority of its revenue from the Floaters segment.